Figure 2.
Percentages of TA patients with variable disease activity at 3-, 6- and 9-month follow ups after LEF and CYC induction.
CYC, cyclophosphamide; LEF, leflunomide; TA, Takayasu’s arteritis.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.